A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 5, 2018

Study Completion Date

June 5, 2018

Conditions
Castrate Refractory Metastatic Prostate Cancer (mCRPC)
Interventions
DRUG

Provenge

Trial Locations (1)

85251

21st Century Oncology, Scottsdale

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Dendreon

INDUSTRY

lead

GenesisCare USA

OTHER